DELAWARE
|
001-37758
|
47-4671997
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File No.)
|
(I.R.S. Employer Identification No.)
|
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).
|
Title of each class
|
Trading Symbol (s)
|
Name of each exchange on which registered
|
Common Stock, par value $.001 per share
|
MBRX
|
The NASDAQ Stock Market LLC
|
•
|
For the 2018/2019 compensation year, Walter V. Klemp, Chief Executive Officer, was granted a cash bonus award of $215,380 and was issued a 10-year option to purchase 500,000 shares of the Company's common stock, under the Company's 2015 Stock Plan, with 4-year annual vesting (i.e., one-quarter of grant vests on the first, second, third and fourth anniversary of the issuance date) and an exercise price equal the closing price of the Company's common stock on the date of approval, or $1.31 per share, and was issued 243,902 restricted stock units vesting in four equal annual installments (i.e., one-quarter of grant vests on the first, second, third and fourth anniversary of the issuance date). For the 2019/2020 compensation year, Mr. Klemp’s base compensation was increased to $500,000, his targeted cash bonus for such year was set at 50% of base compensation, and his targeted equity grant value for such year was set at $900,000; provided that the cash bonus and equity grants for the compensation year are subject to Compensation Committee approval.
|
•
|
For the 2018/2019 compensation year, Jonathan P. Foster, Chief Financial Officer, was granted a cash bonus award of $121,040 and was issued a 10-year option to purchase 315,000 shares of the Company's common stock, under the Company's 2015 Stock Plan, with 4-year annual vesting (i.e., one-quarter of grant vests on the first, second, third and fourth anniversary of the issuance date) and an exercise price equal the closing price of the Company's common stock on the date of approval, or $1.31 per share. For the 2019/2020 compensation year, Mr. Foster’s base compensation was increased to $375,000, his targeted cash bonus for such year was set at 40% of base compensation, and his targeted equity grant value for such year was set at $470,000; provided that the cash bonus and equity grants for the compensation year are subject to Compensation Committee approval.
|
•
|
For the 2018/2019 compensation year, Donald Picker, Chief Science Officer, was granted a cash bonus award of $100,125 and was issued a 10-year option to purchase 100,000 shares of the Company's common stock, under the Company's 2015 Stock Plan, with 4-year annual vesting (i.e., one-quarter of grant vests on the first, second, third and fourth anniversary of the issuance date) and an exercise price equal the closing price of the Company's common stock on the date of approval, or $1.31 per share. For the 2019/2020 compensation year, Dr. Picker’s base compensation was increased to $300,000, his targeted cash bonus for such year was set at 38.3% of base compensation, and his targeted equity grant value for such year was set at $100,000; provided that the cash bonus and equity grants for the compensation year are subject to Compensation Committee approval.
|